日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Differential Hematotoxic Activity of Southeast Asian Pit Viper Venoms: The Cross-Neutralizing Effect of Available Antivenoms

东南亚蝮蛇毒液的差异性血液毒性活性:现有抗蛇毒血清的交叉中和作用

Apipongrat, Dollapak; Ahmad Rusmili, Muhamad Rusdi; Thapanasopon, Kornkanok; Poonaya, Khatsophon; Chantkran, Wittawat; Chaisakul, Janeyuth

Discordance between immunofixation and free light chain assays in multiple myeloma: a retrospective analysis and evaluation of the heavy/light chain assay for disease monitoring

多发性骨髓瘤中免疫固定电泳和游离轻链检测结果不一致:一项回顾性分析及重/轻链检测在疾病监测中的应用评价

Nathalang, Oytip; Onthong, Yupapin; Laoruangroj, Chonlada; Apipongrat, Dollapak

Development of a MassARRAY Genotyping Platform and Its Clinical Application for Venous Thromboembolism Risk Assessment in Thai Patients

MassARRAY基因分型平台的开发及其在泰国患者静脉血栓栓塞风险评估中的临床应用

Apipongrat, Dollapak; Laoruangroj, Chonlada; Nathalang, Oytip; Arnutti, Pasra; Theeraapisakkun, Montalee; Chantkran, Wittawat

Multiplex-PCR technique to predict polymorphic antigens - M, N, S and s - and associations between their alleles and Mi(a)-associated hybrid glycophorins

利用多重PCR技术预测多态性抗原——M、N、S和s——及其等位基因与Mi(a)相关杂合糖蛋白之间的关联

Kerdthip, Thanaporn; Nathalang, Oytip; Chidtrakoon, Sarisa; Choychimplee, Tanaporn; Apipongrat, Dollapak; Intharanut, Kamphon

Serum proteomic profiling reveals MTA2 and AGO2 as potential prognostic biomarkers associated with disease activity and adverse outcomes in multiple myeloma

血清蛋白质组学分析显示 MTA2 和 AGO2 是与多发性骨髓瘤疾病活动性和不良后果相关的潜在预后生物标志物

Dollapak Apipongrat, Sittiruk Roytrakul, Kannadit Prayongratana, Mongkon Charoenpitakchai, Kamphon Intharanut, Chonlada Laoruangroj, Panachai Silpsamrit, Oytip Nathalang